Radiology - Technology Information Portal
Monday, 6 May 2024
• Welcome to Radiology-TIP.com!
     • Sign in / Create account
 
 'Infusion' p2
SEARCH   
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
Searchterm 'Infusion' found in 2 terms [
] and 5 definitions [
]
Result Pages :
Hypaque Sodium
Hypaque Sodium is a high-osmolar, water-soluble contrast agent. In pure form, it contains 59.87 percent organically bound iodine.
The dosage of contrast media is depended on the type of radiological procedure and should be tailored individually according to age, body size, and indication for examination.

Drug Information and Specification
NAME OF COMPOUND
Diatrizoate sodium
MANUFACTURER
INDICATION
Urography, angiography, CT head
APPLICATION
Intravascular
PHARMACOKINETIC
Renal excretion
CHEMICAL BOND
1515 mosm/kgH2O
IODINE CONCENTRATION
300 mg/mL
CT DOSAGE
50 - 100 mL, up to 150 mL by infusion
PREPARATION
Ready-to-use product
STORAGE
Protect from light. Store at 15°Celsius to 30°C (59° Fahrenheit to 86°F).
PRESENTATION
50 mL vials
DO NOT RELY ON THE INFORMATION PROVIDED HERE, THEY ARE NOT A SUBSTITUTE FOR THE ACCOMPANYING PACKAGE INSERT!
Intravenous Pyelogram
(IVP) An intravenous pyelogram is a radiographic study of the kidney, ureters, and bladder. After the injection or infusion of iodinated contrast materials into the vein, the contrast medium is excreted by the kidneys. Due to the higher density of the dye, contrast filled areas appear white on x-ray images.
IVPs are used to detect tumors, abnormalities, kidney stones, or any obstructions, and to assess renal blood flow. A pyelogram may also be performed with contrast media injection directly through a ureteral or nephrostomy catheter or percutaneously.

See also X-Ray Projection Imaging, Abdomen CT and Urologic Ultrasound.
Result Pages :
 
Share This Page
Facebook
Twitter
LinkedIn
Look
      Ups
Radiology - Technology Information Portal
Member of SoftWays' Medical Imaging Group - MR-TIP • Radiology-TIP • Medical-Ultrasound-Imaging
Copyright © 2008 - 2024 SoftWays. All rights reserved.
Terms of Use | Privacy Policy | Advertising
 [last update: 2023-11-06 02:01:00]